Perception and practice of sublingual immunotherapy among practicing allergists

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 4, 2008, Pages 419-425

  Tucker, Mark H ^a   Tankersley, Michael S ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ALLERGIST; ARTICLE; ASTHMA; CHILD; CLINICAL PRACTICE; DRUG ADMINISTRATION ROUTE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; INFANT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY;

EID: 53549083807     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60320-1     Document Type: Article

References (33)

1. Curtis H. The immunizing cure of hay fever. Med News. 1900;74:16-18.
2. Black J. The oral administration of pollen. J Lab Clin Med. 1927;12:1156.
3. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systemic review and meta-analysis. Allergy. 2005;60:4-12.
4. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117:1021-1035.
5. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases [WHO position paper]. J Allergy Clin Immunol. 1998;102:558-562.
6. Malling HJ, Abreu-Nogueira. EAACI/ESPACI position paper on local immunotherapy. Allergy 1998;53:833-844.
7. Bousquet J, Van Cauwenberge. Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-S334.
8. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol. 1993;91:734-737.
9. Lower T, Henry J, Mandik L, Janosky J, Friday G. Compliance with allergen immunotherapy. Ann Allergy Asthma Immunol. 1995;70:480-481.
10. Tinkelman D, Smith F, Cole W, Silk H. Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol. 1995;74:241-246.
11. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol. 2002;88:391-394.
12. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol. 1999;82:281-286.
13. Pajno GR, Vita D, Caminiti L, et al. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol. 2005;116:1380-1381.
14. Lombardi C, Gani F, Landi M, et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol. 2004;113:1219-1220.
15. Hankin CS, Cox L, Lang D, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol. 2008;121:227-232.
16. Canonica G, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol. 2003;111:437-448.
17. Dunsky EH, Goldstein MF, Dvarin DJ, Belecanech GA. Anaphylaxis to sublingual immunotherapy. Allergy. 2006;61:1235.
18. Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy. 2007;62:567-568.
19. Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy. 2006;61:1236.
20. Lombardi C, Gargioni S, Melchiorre A, et al. Safety of sublingual immunotherapy with monomeric allergoid in adults: a multicenter postmarketing surveillance study. Allergy. 2001;56:989-992.
21. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on safety of sublingual immunotherapy in pediatric patients. Allergy. 1999;54:1110-1113.
22. Fiocchi A, Pajno G, La Grutta S, et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol. 2005;95:254-258.
23. Pajno GB, Peroni DG, Vita D, Pietrobelli A, Parmiani S, Boner AL. Safety of sublingual immunotherapy in children with asthma. Pediatr Drugs. 2003;5:777-781.
24. Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. Allergol Immunopathol. 1995;23:224-230.
25. Coop CA, Tankersley MS. Dose adjustments among allergists for local reactions from immunotherapy. Ann Allergy Asthma Immunol. 2007;99:77-81.
26. Didlier A, Malling H-J, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol. 2007;120:1338-1345.
27. Berto P, Passalacqua G, Crimi N, et al. Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with polleninduced respiratory allergy: the sublingual immunotherapy pollen allergy Italy (SPAI) study. Ann Allergy Asthma Immunol. 2006;97:615-621.
28. Cox L, Li J, Nelson H, Lockey R. Allergen immunotherapy: a practice parameter. J Allergy Clin Immunol. 2007;120:S25-S85.
29. Greenberger PA, Ballow M, Casale TB, Platts-Mills TAE, Sampson HA. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States. J Allergy Clin Immunol. 2007;120:1466-1468.
30. Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy. 2008;63:374.
31. Rienzo V, Minelli M, et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy. 2005;35:560-564.
32. Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol. 2001;87(suppl):47-55.
33. Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol. 2006;117:169-175.